Long cervicothoracic posterior instrume ntation and fusion: A retrospective complication analysis of 15 years of ACS-NSQIP data
BACKGROUND: Long cervicothoracic posterior instrumentation and fusion carries known perioperative risk, yet 30-day morbidity and independent predictors remain poorly characterized at scale. Therefore, this study aims to provide a multi-institutional analysis of 30-day adverse events and predictors of morbidity following long cervicothoracic posterior instrumentation and fusion. METHODS: Patients undergoing long cervicothoracic posterior instrumentation and fusion (2010-2024) were identified in the ACS-NSQIP database using a CPT-derived cohort definition framework composed of three query pathways, utilizing primary procedure codes for cervical arthrodesis, thoracic arthrodesis, and multi-level posterior segmental instrumentation. The primary outcome was any adverse event (AAE) within 30 days. Secondary outcomes included major, minor and infection-related complications. Exploratory multivariable logistic regression identified independent associations with AAE, with threshold analysis performed for significant continuous predictors. RESULTS: ). AAE occurred in 30.2% of patients, most commonly postoperative transfusion (16.6%) and return to the operating room (7.7%). Major, minor, and infection-related complications occurred in 25.1%, 11.1%, and 9.8% of patients, respectively, while 30-day mortality was 0.9%. Operative time (odds ratio [OR] = 1.004), chronic steroid use (OR = 7.080), medication-required hypertension (OR = 2.677), and neoplastic/pathologic fracture diagnostic family relative to the degenerative/myelopathic reference family (OR = 4.804) were independently associated with AAE. Threshold analysis identified a 495.5-minute operative time cut-point (95th percentile), above which the AAE rate increased from 27.8% to 75.0% (OR = 7.935), highlighting disproportionate morbidity among extreme cases. CONCLUSION: Nearly one-third of patients experienced a 30-day adverse event following long cervicothoracic posterior instrumentation and fusion, with considerably elevated risk concentrated among exceptionally prolonged surgeries. Identified predictors further characterize the procedure-specific perioperative profile of this cohort and may help to inform risk stratification and case planning, pending validation through future large-scale, longitudinal investigation.
Authors
- Nitin Narain Bhatia (ORCID: https://orcid.org/0000-0001-7905-3305)
- Emily S. Mills (ORCID: https://orcid.org/0000-0002-1777-2969)
- Hana-Joy E. Hanks (ORCID: https://orcid.org/0009-0003-4283-9293)
- Carla Guedikian (ORCID: https://orcid.org/0009-0005-8499-3955)
- Arthur W. Cowman (ORCID: https://orcid.org/0009-0007-0444-1558)
- Melissa R. Romoff (ORCID: https://orcid.org/0009-0009-1881-9923)
- Shahabeddin Yazdanpanah (ORCID: https://orcid.org/0009-0002-9047-8712)
- Sultan Baz (ORCID: https://orcid.org/0009-0004-7958-7357)
- Shishir Ravipati
- Yu-Po Lee
- Hao-Hua Wu
- Sohaib Z. Hashmi
- Don Y. Park
Institutions
- University of California, Irvine (US)
- University of Rochester (US)
- Northeast Ohio Medical University (US)
Publication Details
- Journal
- Journal of Clinical Neuroscience
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1016/j.jocn.2026.112408
- Primary Topic
- Cervical and Thoracic Myelopathy
- Type
- article
- Field-Weighted Citation Impact
- 0.00